Sub menu

 

 

APO-PACLITAXEL, PACLITAXEL APOTEX (Apotex Pty Ltd)

Product name
APO-PACLITAXEL, PACLITAXEL APOTEX
Sponsor
Apotex Pty Ltd
Date registered
Evaluation commenced
Decision date
Approval time
253 working days (255)
Active ingredients
paclitaxel
Registration type
New generic medicine
Indication
Metastatic Breast Cancer

Albumin-bound APO-PACLITAXEL, PACLITAXEL APOTEX (powder for injection) are indicated for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy.

Help us improve this page